Related Experiment Video
Updated: May 2, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Is it time to lower the bar for bariatric surgery?
1Obesity Research and Management, University of Alberta, Li Ka Shing Building, Rm 1-116, 87th Avenue and 112th Street, Edmonton, AB, T6G 2E1, Canada, amsharm@ualberta.ca.
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) suggests considering bariatric surgery for patients with class 1 obesity and comorbidities who have not succeeded with other treatments. Further research is needed to evaluate this new approach.
Area of Science:
- Metabolic Disorders
- Bariatric Surgery
- Obesity Treatment
Background:
- Current guidelines for bariatric surgery primarily focus on higher Body Mass Index (BMI) categories.
- Nonsurgical obesity treatments often fail for individuals with significant comorbidities.
- The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has issued new recommendations.
Purpose of the Study:
- To analyze the IFSO's new position statement regarding surgical interventions for obesity.
- To evaluate the implications of considering surgery for patients with class 1 obesity (BMI 30-35 kg/m²).
- To highlight the need for assessing outcomes, cost-effectiveness, and access to care for this patient group.
Main Methods:
- Review of the IFSO position statement.
- Analysis of current BMI-based obesity treatment guidelines.
- Discussion of the arbitrary nature of BMI thresholds.
- Consideration of patient profiles with significant comorbidities and failed nonsurgical treatments.
Main Results:
- IFSO recommends considering surgery for class 1 obesity patients with comorbidities who failed nonsurgical options.
- This reflects a potential shift from strict BMI-based criteria.
- The recommendations challenge the arbitrary nature of current BMI cutoffs.
Conclusions:
- The new IFSO recommendations broaden the criteria for bariatric surgery consideration.
- Careful assessment of outcomes, cost-effectiveness, and access is crucial for this expanded patient group.
- Further research is essential to validate this new approach in managing obesity.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Drug Dosing: Obese Patients
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

